YAHOO! FINANCE – The FDA, on Aug 22, approved/authorized the updated mRNA-based COVID-19 vaccines of Pfizer PFE/BioNTech BNTX and Moderna MRNA that target the...
Those doses would potentially be used to inoculate farm workers and others at risk of exposure to the virus. For the general public, U.S. and global health officials say the risk from bird flu remains low.
CBC News – Moderna is developing a three-in-one vaccine against COVID-19, flu and RSV.
The vaccine manufacturer is actively promoting the shot and hoping for...
Bloomberg – Annual US sales of Covid-19 shots could be high as $12.9 billion, with health officials likely recommending an annual booster, vaccine maker...
(Headline USA) COVID-19 vaccine maker Moderna is suing Pfizer and the German drugmaker BioNTech, accusing its main competitors of copying Moderna’s technology in order...
ARS TECHNICA – A COVID-19 booster targeting two versions of the coronavirus in one shot offered stronger and broader protection than the current booster,...
Moderna hopes to offer updated COVID-19 boosters in the fall that combine its original vaccine with protection against the omicron variant. On Tuesday, it reported a preliminary hint that such an approach might work.
Moderna Is Developing 2 New Vaccines—And 1 Could Protect Against the Common Cold
The two vaccines aim to reduce the impact of respiratory illnesses on...
Recent Comments